Author:
Verrienti Martina,Zatelli Maria Chiara,Ambrosio Maria Rosaria,
Publisher
Springer Science and Business Media LLC
Reference7 articles.
1. Bartalena L, Baldeschi L, Boboridis K, et al. , for the European Group on Graves’ Orbitopathy (EUGOGO) (2016) The 2016 European Thyroid Association/European Group on Graves’ Orbitopathy guidelines for the management of Graves’ orbitopathy. Eur Thyroid J 5(1):9–26
2. Pelewicz-Sowa M, Miśkiewicz P (2023) Dysthyroid optic neuropathy: emerging treatment strategies. J Endocrinol Invest 46(7):1305–1316
3. Bartalena L (2019) Sight-threatening graves’ ophthalmopathy [updated 2019 jan 3]. In: Feingold KR, Anawalt B, Blackman MR et al. (eds) Endotext [Internet]. MDText.com, South Dartmouth. Available from https://www.ncbi.nlm.nih.gov/books/NBK279098/
4. Verrienti M, Aliberti L, Valente L et al. (2023) Inquadramento diagnostico dell’Orbitopatia di Graves. Endocrinologo 24(Suppl 1):77–80
5. Monteiro ML, Gonçalves AC, Silva CT et al. (2008) Diagnostic ability of Barrett’s index to detect dysthyroid optic neuropathy using multidetector computed tomography. Clinics (Sao Paulo) 63(3):301–306